STOCK TITAN

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Verrica Pharmaceuticals (Nasdaq: VRCA), a company focused on developing dermatology therapeutics, announced that its President and CEO, Ted White, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City.

The event will take place on June 6, 2024, at 3:30 pm ET. A live webcast of the event will be available through the investors' section of the Verrica website, with a replay accessible for 90 days post-event.

Loading...
Loading translation...

Positive

  • Verrica Pharmaceuticals' participation in a major healthcare conference enhances visibility among investors and industry stakeholders.
  • Availability of a live webcast and replay increases accessibility and transparency for investors.

Negative

  • The press release lacks any direct financial or clinical updates which could provide substantial information for investors to assess the company's performance.
Argus Session date unavailable
+2.16% session move Open Argus
Details

News Market Reaction – VRCA

The recorded move for VRCA in the trading session of this news was +2.16%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City.

Jefferies Global Healthcare Conference, New York, June 6, 2024.
Event details:
Date: Thursday, June 6, 2024
Time: 3:30 pm ET
Location: New York, NY

Participants may access a live webcast of the event by clicking the link here.

The webcast can also be accessed in the Investors/Presentations & Events section of the Verrica website at www.verrica.com. A replay of the webcast will be posted shortly after the presentation and will be available for 90 days following the event.

About Verrica Pharmaceuticals Inc. 

Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica’s product YCANTH (cantharidin), is the first and only commercially available treatment approved by the FDA to treat adult and pediatric patients two years of age and older with molluscum contagiosum, a highly contagious viral skin infection affecting approximately 6 million people in the United States, primarily children. VP-102 is also in development to treat common warts and external genital warts, two of the largest remaining unmet needs in medical dermatology. Verrica is developing VP-103, its second cantharidin-based product candidate, for the treatment of plantar warts. Verrica has also entered a worldwide license agreement with Lytix Biopharma AS to develop and commercialize VP-315 (formerly LTX-315 and VP-LTX-315) for non-melanoma skin cancers including basal cell carcinoma and squamous cell carcinoma. For more information, visit www.verrica.com.

FOR MORE INFORMATION, PLEASE CONTACT:

Investors:

Terry Kohler 
Chief Financial Officer 
tkohler@verrica.com

Kevin Gardner 
LifeSci Advisors 
kgardner@lifesciadvisors.com

Chris Calabrese 
LifeSci Advisors 
ccalabrese@lifesciadvisors.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date and time of Verrica Pharmaceuticals' participation in the Jefferies Global Healthcare Conference?

Verrica Pharmaceuticals will participate in the Jefferies Global Healthcare Conference on June 6, 2024, at 3:30 pm ET.

How can investors access the live webcast of Verrica Pharmaceuticals' presentation at the Jefferies Global Healthcare Conference?

Investors can access the live webcast through the Investors/Presentations & Events section of the Verrica website.

Will there be a replay available for Verrica Pharmaceuticals' presentation at the Jefferies Global Healthcare Conference?

Yes, a replay of the webcast will be available for 90 days following the event.

Keep reading